• 24/03/2022

    ASCENT project: invest in innovative digital tools to end TB

    The Unitaid-funded ASCENT project has entered its final year and is well on its way in showing the benefits…

    Lees meer

  • 24/03/2022

    TREATS releases final report

    The TREATS (Tuberculosis Reduction through Expanded Antiretroviral Treatment and Screening for Active TB) project has just released its…

    Lees meer

  • 24/03/2022

    IMPAACT4TB raises awareness and access to TB Preventative Treatment

    About a quarter of the world’s population is infected with Mycobacterium Tuberculosis and thus at risk of developing tuberculosis (TB)…

    Lees meer

  • 24/03/2022

    KardiaMobile for ECG monitoring: Innovative approach to help DR-TB patients in Kazakhstan

    KNCV is constantly looking for innovative approaches for patient-centered care. Patients with drug resistant tuberculosis (DR-TB) who receive treatment with…

    Lees meer

  • 04/03/2022

    Save the date: Wolfheze Workshops 2022

    Regaining lost ground: ending TB in Europe 16th WHO National TB Programme Managers’ Meeting and 20th Wolfheze Workshops…

    Lees meer

  • 28/02/2022

    New platform on digital adherence technologies for tuberculosis treatment

    As a part of the Global digital adherence technology (DAT) Task Force, KNCV Tuberculosis Foundation is pleased to announce the…

    Lees meer

  • 21/02/2022

    Dr. Bakyt Myrzaliev receives ‘Award for Partnership to End TB’

    Dr. Bakyt Myrzaliev, KNCV representative in Kyrgyzstan, has been awarded the ‘Award for Partnership to End TB’ by the…

    Lees meer

  • 24/01/2022

    Our sincere condolences for the passing of Dr. Lucie Blok

    The world of public health has lost a great colleague with a passion for teaching and quality public health response,…

    Lees meer

  • 24/01/2022

    Rest in peace, Dr. Baba Awe

    TB Program Nigeria, Afrika and the world will greatly miss the dedicated and passionate Dr. Baba Awe. He has spent…

    Lees meer

  • 21/01/2022

    Success for AMR Global with ‘GLORIA’

    AMR-Global has successfully secured co-funding from the PPP Allowance made available by Health~Holland, Top Sector Life Sciences & Health,…

    Lees meer

  • 10/12/2021

    Optimized models of care for TB prevention among migrants

    On Tuesday, 7 December 2021, the symposium “TB prevention among high-risk migrants in low-burden countries” was held online. The symposium…

    Lees meer

  • 20/11/2021

    On World Children’s Day, KNCV celebrates improved access to diagnosis of TB in children

    Today, on World Children’s Day, we welcome the updated guidance published by the…

    Lees meer

  • 12/11/2021

    KNCV Nigeria awarded at the National TB Conference

    At the National TB Conference in Nigeria, organized by the Stop TB Partnership Nigeria and National TB and…

    Lees meer

  • 08/11/2021

    Calling on the Global Fund to urgently increase allocations for TB

    Today KNCV Tuberculosis Foundation jointly with 57 tuberculosis (TB) civil society and community organizations ask the Board of the…

    Lees meer

  • 03/11/2021

    Establishing a global market for digital adherence technologies

    As part of the ASCENT project, funded by Unitaid,…

    Lees meer
Bezoek Nederlandse website

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Cambodia
Eswatini
Ethiopia
Indonesia
Kazakhstan
Kenya
Kyrgyzstan
Namibia
Nigeria
Tajikistan
Tanzania
Ukraine
Vietnam
Zambia

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

KNCV’s Key Technical Assistance Intervention Pathways

Improved scientific methods and models to end TB

Stronger health systems, data driven planning

Zero TB related stigma

Optimized digital health solutions along the patient pathway

TB vaccine access strategies

New Diagnostics and Laboratory Network Design

New drugs & treatment regimens

Diagnosis & treatment of LTBI

People-Centred Framework for TB Programming: Development of Optimized National Strategic Plans

Childhood TB – KNCV Benchmarking Tool for TB in Children and Adolescents

Current Projects

ASCENT
ASTTIE
ETBE Project
Evaluation of SeroSelectTB
GeneXpert MTB/RIF Test
iDEFEAT TB Project
IMPAACT4C19
IMPAACT4TB
LIFT-TB 
No More Pandemics
PANGenS
People-Centered Framework for TB Programming (PCF)
Triage Test for All Oral DR TB Regimen (TriAD)
SMART4TB
The Global Fund to Fight AIDS, Tuberculosis and Malaria

Completed Projects

Challenge TB
Development of a comprehensive Digital Training Package
E-detect
Improved TB/HIV Prevention & Care – Building Models for the Future Project
PAVIA
PODTEC
TB REACH Ethiopia
TB REACH Nigeria
TB REACH Philippines
TB REACH Tanzania
TREATS

KNCV Webinar: Impact of COVID-19: Hear the perspective of TB/MDR-TB patients and front line health care workers
KNCV Webinar: Contact Investigation for COVID-19: Lessons from TB Control Programs
KNCV Webinar ‘Infection prevention and control for COVID-19

KNCV’s Technical Assistance package

Annual Reports

KNCV’s SOS Stoolbox

KNCV Benchmarking Tool for TB in Children and Adolescents

KNCV’s People Centered Framework (Handbook, Dashboard, Toolkit)

KNCV’s Success Stories from IMPAACT4TB – 4 countries

KNCV’s Success Stories from IMPAACT4TB – Malawi

TB Stigma Measurement Guidance

From the Inside Out – Dealing with TB-related Self-stigma and Shame

Allies Approach – The KNCV Stigma Reduction Toolbox

KNCV 2-pager TB Photovoices

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.